LATEST

• REGULATORY Takaichi Defends Off-Year Drug Price Revisions as DPP Calls for Abolition
  October 9, 2026

• BUSINESS TOPIX Shuffle Puts Mid-Tier Drug Makers, Wholesalers on Chopping Block
  October 9, 2026

• ORGANIZATION PhRMA Sues CMS over Medicare MFN Model, Calls It Unlawful Overreach
  October 9, 2026

• REGULATORY Japan Orders Contraindication for Adlumiz-Noxafil Combination
  October 9, 2026

• ORGANIZATION Japan Generic Group Calls for Clearer Patent Extension Rules
  October 9, 2026

• BUSINESS Ono Gets Japan, Asia Rights to 3 IgG Degraders from Biohaven
  October 9, 2026

• BUSINESS Datroway Snares TNBC Approval in China: Daiichi Sankyo
  October 9, 2026

• BUSINESS Enhertu Gains Adjuvant Nod in China for HER2-Positive Breast Cancer
  October 9, 2026

• REGULATORY Imcivree, Hibsago Get Chuikyo Nod for Home Self-Injection
  October 9, 2026

• REGULATORY Provider-Payer Tug-of-War Takes Shape over FY2027 Drug Price Revision
  October 8, 2026

• BUSINESS Parexel Revs Up AI Drive, Targets 6-Month Trial Time Cut
  October 8, 2026

• ORGANIZATION 3 Pharma Groups Press Government to Rethink CEA Expansion
  October 8, 2026

• REGULATORY Imulrio Finally Set for NHI Listing after 296-Day Wait; Zero Rule Strikes Again
  October 8, 2026

• REGULATORY Japan Panel to Mull Hernexeos 1st-Line Use, Rinvoq Alopecia Expansions
  October 8, 2026

• ORGANIZATION JPMA Chief Urges Manufacturing, Talent Push to Build Drug Discovery Ecosystem
  October 8, 2026

• BUSINESS FDA Accepts BridgeBio’s Infigratinib NDA for Achondroplasia
  October 8, 2026

• BUSINESS Eylea 8 mg Shows Vision Gains in 24-Week Analysis
  October 8, 2026

• BUSINESS Boehringer, Hiroshima Tie Up on Health Promotion
  October 8, 2026

• BUSINESS Japan Ethical Drug Sales Up 3% in August: Crecon
  October 8, 2026

• BUSINESS PeptiDream Earns Milestone Payment from US Merck
  October 8, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »